neoadjuvant — Drug Profile | NovaPharmaNews

Quick answer

neoadjuvant is an FDA-listed pharmaceutical active ingredient.

Key facts

INN neoadjuvant

Approval history

Authority	Status	Date
NMPA	clinical trials	—

Pipeline programs

Search pipeline

Adjuvant chemotherapy Phase 3 · Chinese Academy of · Total Neoadjuvant Treatment
Datopotamab deruxtecan for Stage I-III Triple-negative Bre… Phase 3 · AstraZeneca · Stage I-III Triple-negative Breast Cancer with residual inva
HIPEC with neoadjuvant chemotherapy Phase 3 · Chinese Academy of · Gastric Cancer
PEMBROLIZUMAB Phase 3 · Ningbo Cancer Hospital · Patient with early triple-negative breast cancer (TNBC) achi
Tislelizumab（neoadjuvant） Phase 3 · Chinese Academy of · Head and Neck Squamous Cell Carcinomas
neoadjuvant chemotherapy Phase 3 · Chinese Academy of · Epithelial Ovarian Cancer
ASND0029 Phase 2 · Anaxis Pharma · Locally advanced or metastatic solid tumor malignancies, pla
Apatinib Phase 2 · First People's Hospital · Systematic Review of the pCR Rate of Apatinib Combined With

Frequently asked questions

What is neoadjuvant?

neoadjuvant is an FDA-listed pharmaceutical active ingredient.